Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy.
TLDR
The structural modifications of MDP and its derivatives have been extensively studied in an attempt to increase adjuvant activity and boost the immune response effectively for clinical use in the treatment of cancer and other diseases.Abstract:
Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. It was first identified in bacterial cell wall peptidoglycan as an active component in Freund's complete adjuvant. In the cell, MDP is detected by NOD2, a cytoplasmic receptor belonging to the human innate immune system. NOD2 mutations are frequently observed in patients with Crohn's disease, an autoimmune disorder, suggesting the significance of the MDP-NOD2 pathway in activating immunity. For this reason, structural modifications of MDP and its derivatives have been extensively studied in an attempt to increase adjuvant activity and boost the immune response effectively for clinical use in the treatment of cancer and other diseases. This review summarizes the synthetic chemistry of MDP and its derivatives and discusses their pharmacological action and stereoselective synthesis.read more
Citations
More filters
Journal ArticleDOI
Liposomes as vaccine delivery systems: a review of the recent advances
TL;DR: This review concentrates on recent and relevant studies emphasizing current reports dealing with the most studied antigens and adjuvants, and pertinent examples of vaccines.
Journal ArticleDOI
Peptide-based cancer therapy: Opportunity and challenge
TL;DR: This review presents the sources and mechanisms of anticancer peptides and further discusses modification strategies to improve the anticancer effects of bioactive peptides.
Journal ArticleDOI
Therapeutic targeting of trained immunity
Willem J. M. Mulder,Jordi Ochando,Jordi Ochando,Leo A. B. Joosten,Leo A. B. Joosten,Zahi A. Fayad,Mihai G. Netea,Mihai G. Netea +7 more
TL;DR: The mechanisms responsible for the induction of trained immunity are described and strategies to regulate it are proposed as a potential treatment of immune-related diseases.
Journal ArticleDOI
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition.
Bram Priem,Mandy M. T. van Leent,Mandy M. T. van Leent,Abraham J. P. Teunissen,Alexandros Marios Sofias,Alexandros Marios Sofias,Vera P. Mourits,Lisa Willemsen,Emma D. Klein,Roderick S. Oosterwijk,Anu E. Meerwaldt,Anu E. Meerwaldt,Jazz Munitz,Geoffrey Prévot,Anna Vera D Verschuur,Sheqouia A. Nauta,Esther M. van Leeuwen,Elizabeth L. Fisher,Karen A.M. de Jong,Yiming Zhao,Yohana C. Toner,Georgios Soultanidis,Claudia Calcagno,Paul H. H. Bomans,Heiner Friedrich,Nico A. J. M. Sommerdijk,Thomas Reiner,Thomas Reiner,Raphaël Duivenvoorden,Raphaël Duivenvoorden,Eva Zupančič,Julie Di Martino,Ewelina Kluza,Mohammad Rashidian,Hidde L. Ploegh,Rick M. Dijkhuizen,Sjoerd Hak,Carlos Pérez-Medina,Carlos Pérez-Medina,Jose Javier Bravo-Cordero,Menno P.J. de Winther,Leo A. B. Joosten,Leo A. B. Joosten,Andrea van Elsas,Zahi A. Fayad,Alexander Rialdi,Denis Torre,Ernesto Guccione,Jordi Ochando,Jordi Ochando,Mihai G. Netea,Mihai G. Netea,Mihai G. Netea,Arjan W. Griffioen,Willem J. M. Mulder +54 more
TL;DR: It is shown that rationally designed nanobiologics can promote trained immunity and elicit a durable anti-tumor response either as a monotherapy or in combination with checkpoint inhibitor drugs.
Journal ArticleDOI
Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components.
TL;DR: It is shown that activation of Nod2 by its ligand, muramyl dipeptide in the bacterial cell wall, induces rapid degradation of NOD2, which confers MDP tolerance in vitro and in vivo, which indicates that TLRs and NLRs induce a tolerant state through distinct molecular mechanisms that protect the host from septic shock.
References
More filters
Journal ArticleDOI
Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations
Jing Li,Thomas M. Moran,Eric Swanson,Christina Julian,Jeremy Harris,Denise K. Bonen,Matija Hedl,Dan L. Nicolae,Clara Abraham,Judy H. Cho +9 more
TL;DR: It is suggested that a signaling defect of innate immunity to MDP may be an essential underlying defect in the pathogenesis of some CD patients, and post-transcriptional dependency on the NOD2/CARD15 pathway for IL-1beta secretion with MDP and TNFalpha treatment is demonstrated.
Journal ArticleDOI
Role of Nod2 in the Response of Macrophages to Toll-Like Receptor Agonists
TL;DR: The results argue that Nod2 does not play an essential, nonredundant role in the response of macrophages to bacterial products but rather plays unexpected roles in regulating systemic responses to pathogens.
Journal ArticleDOI
The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation.
TL;DR: This paper presents a meta-analyses of the HIT database that shows clear trends in the number of hits over time and in the severity of the crashes that occur after a single event.
Journal ArticleDOI
Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-ΚB activation in muramyl dipeptide recognition
Nicolas Barnich,Jose E. Aguirre,Hans Christian Reinecker,Ramnik J. Xavier,Daniel K. Podolsky +4 more
TL;DR: In this paper, the authors performed a functional analysis of deletion and substitution NOD2 mutants, but not NOD 2 3020insC mutant, associated with cell surface membranes of intestinal epithelial cells.
Journal ArticleDOI
The NOD: a signaling module that regulates apoptosis and host defense against pathogens.
Naohiro Inohara,Gabriel Núñez +1 more
TL;DR: Nods activate, through the NOD module, diverse signaling pathways involved in the elimination of cells via PCD and the host defense against pathogens.